Literature DB >> 23945024

Spontaneous uterine rupture at 32 weeks of gestation after previous uterine artery embolization.

Jun Takeda1, Shintaro Makino, Atsuyuki Ota, Tetsuo Tawada, Naoki Mitsuhashi, Satoru Takeda.   

Abstract

Uterine artery embolization (UAE) is a common treatment for post-partum hemorrhage and uterine fibroids. However, the effects of UAE on subsequent pregnancies have not been established. Here, we present a case of spontaneous uterine rupture after previous UAE. A 31-year-old woman underwent UAE for a cervical ectopic pregnancy. Contrast-enhanced magnetic resonance imaging (MRI) at days 5 and 25 post-UAE suggested a regionally decreased blood supply in the mid-posterior wall of the uterine fundus. During a subsequent pregnancy at age 35 years, she underwent an emergency cesarean delivery due to spontaneous uterine rupture at the mid-posterior wall of the uterus at 32 weeks of gestation. Obstetricians should be attentive to the possibility of spontaneous uterine rupture in pregnant women who have previously undergone UAE. Detection of ischemic uterine muscle on MRI may predict potential for uterine rupture in a subsequent pregnancy.
© 2013 The Authors. Journal of Obstetrics and Gynaecology Research © 2013 Japan Society of Obstetrics and Gynecology.

Entities:  

Keywords:  magnetic resonance imaging; pregnancy; side-effects; uterine artery embolization; uterine rupture

Mesh:

Year:  2013        PMID: 23945024     DOI: 10.1111/jog.12122

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  2 in total

1.  Spontaneous rupture of uterine leiomyoma during labour.

Authors:  Nikki Ramskill; Aisha Hameed; Yusuf Beebeejaun
Journal:  BMJ Case Rep       Date:  2014-09-08

2.  Abdominal Myomectomy for Huge Uterine Myomas with Intra-arterial Balloon Occlusion: Approach to Reduce Blood Loss.

Authors:  Satoru Takeda; Tsuyoshi Ota; Hiroshi Kaneda; Yasuhisa Terao; Ryohei Kuwatsuru
Journal:  Surg J (N Y)       Date:  2019-08-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.